About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline



25 Anglo-Am. L. Rev. 286 (1996)
Causation and Drugs: The Legacy of Diethylstilbestrol

handle is hein.journals/comlwr25 and id is 300 raw text is: ANGLO-AMERICAN LAW REVIEW

CAUSATION AND DRUGS:
THE LEGACY OF DIETHYLSTILBESTROL
By RICHARD GOLDBERG
I. Introduction and Background
One of the most controversial areas of product liability is that of
establishing causation in drug-induced injury cases. Nowhere is
this task more challenging than in the context of those drugs
which may have an inherent propensity to harm successive
generations. Diethylstilbestrol (DES), which was used as an
oestrogenic hormone, is possibly the classic paradigm of the
potential for generational drug-induced defects. The principal
established adverse drug reaction associated with DES is that of
second generation vaginal adenosis and vaginal clear cell
adenocarcinoma. A causal link between DES and vaginal
adenocarcinoma and adenosis has been established for over 20
years.1
The effect of DES on the second generation, ie, the daughters
who were foetuses in utero when their mothers took the drug can
be distinguished from third generation cases which have alleged
that DES can cause reproductive abnormalities in the second
generation, resulting in the premature birth of third generation
children with physical disabilities, including cerebral palsy. There
are also alleged cases of DES causing chromosomal damage to
1.    Herbst, Ulfelder and Poskanzer, Adenocarcinoma of the Vagina.
Association of Maternal Stilbestrol Therapy with Tumour Appearance
in Young Women (1971) 284 N. Eng. J. Med. 878, 878, 879. Strict
epidemiological analyses of data have pointed to shortcomings in such
evidence: McFarlane, Feinstein and Horwitz,  Diethylstilbestrol and Clear
Cell Vaginal Carcinoma. Reappraisal of the Epidemiologic Evidence
(1986) 81 Am. J. Med., 855-863. However, the McFarlane et al. study has
been convincingly criticized in Buitendijk, Diethylstilbestrol and the
next generation: a challenge tothe evidence? in Dukes and Beeley (eds.)
Side Effects of Drugs Annual 12, (Amsterdam, New York and Oxford:
Elsevier, 1988), pp.347-348.